Angiotensin Receptor Blocker and Calcium Channel Blocker Preventing Atrial Fibrillation Recurrence in Patients with Hypertension and Atrial Fibrillation: A Meta-analysis
Background. Atrial fibrillation (AF) is the most common serious cardiac rhythm disturbances and is responsible for substantial morbidity and mortality in general population. Hypertension is the most prevalent and potentially modifiable risk factor for AF. This study is aimed at evaluating the effect...
Príomhchruthaitheoirí: | Haotian Ma, Hongcheng Jiang, Jing Feng, Yong Gan |
---|---|
Formáid: | Alt |
Teanga: | English |
Foilsithe / Cruthaithe: |
Hindawi-Wiley
2021-01-01
|
Sraith: | Cardiovascular Therapeutics |
Rochtain ar líne: | http://dx.doi.org/10.1155/2021/6628469 |
Míreanna comhchosúla
Míreanna comhchosúla
-
Angiotensin II receptor blockers in the prevention of complications from atrial fibrillation
de réir: Gerald V Naccarelli, et al.
Foilsithe / Cruthaithe: (2009-09-01) -
Angiotensin II receptor blockers and cardiovascular protection: Focus on left ventricular hypertrophy regression and atrial fibrillation prevention
de réir: Cesare Cuspidi, et al.
Foilsithe / Cruthaithe: (2008-02-01) -
A combined role of calcium channel blockers and angiotensin receptor blockers in stroke prevention
de réir: Ji-Guang Wang
Foilsithe / Cruthaithe: (2009-07-01) -
Long-term observation of fibrillation cycle length in patients under angiotensin II receptor blocker therapy for chronic atrial fibrillation
de réir: Jun Kishihara, et al.
Foilsithe / Cruthaithe: (2012-02-01) -
Left Atrial Function in Different Modes of Heart-Rate Lowering Therapy with Beta-Blockers in Patients with Recurrent Atrial Fibrillation and Hypertension
de réir: E. V. Kokhan, et al.
Foilsithe / Cruthaithe: (2021-07-01)